Abstract
Since the introduction of labeled dexamethasone to detect and characterize the glucocorticoid receptor, the use of labeled synthetic hormones as tracers has become increasingly widespread. The progestin receptor is now rarely assayed with labeled progesterone, but with radioligands such as [3H]promegestone (Duffy and Duffy, 1979; McGuire et al., 1977b; Horwitz and McGuire, 1975; Philibert and Raynaud, 1973, 1974a, b) and [3H]-ORG 2058 (Keightley, 1979; Koenders et al.,1979; Jänne et al., 1978; Fleischmann and Beato, 1978); the androgen receptor is assayed with [3H]metribolone rather than labeled dihydrotestosterone (Raynaud et al., 1980a; Ekman et al.,1979b; Ghanadian et al., 1978; Menon et al.,1978; Shain and Boesel, 1978; Cowan et al.,1977; Asselin et al.,1976a; Bonne and Raynaud, 1975, 1976), and the estrogen receptor can, in the opinion of several authors, often be unambiguously detected only with ligands such as [3H]moxestrol (MacLusky et al., 1979a, b; Martin et al.,1978; Okret et al., 1978; Raynaud et al.,1978; Raynaud and Moguilewsky, 1976, 1977; McEwen et al.,1975; Raynaud, 1974). The reasons underlying the ever-increasing use of these synthetic radioligands (tags) are to be found in the distinct advantages they offer over labeled natural hormones as described previously in some detail (Raynaud et al., 1979b) and as briefly summarized herein. Unlike the natural hormones, tags do not bind with high affinity to the plasma proteins that often contaminate tissue and cytosol preparations (Ballard, 1979; Hähnel and Twaddle, 1979; Krieg et al., 1979; Karr et al., 1978; Wagner, 1978). Unlike estradiol, testosterone, and dihydrotestosterone, neither moxestrol nor metribolone binds extensively to human sex-steroid-binding protein (SBP); unlike progesterone, hydrocortisone, and aldosterone, neither promegestone nor dexamethasone binds with high affinity to human corticosteroid-binding globulin (CBG). Furthermore, tags are resistant to degradation and form more stable (slowly dissociating) receptor complexes than the natural hormones, thus facilitating the detection of receptors and enabling their measurement by exchange assay. For instance, metribolone, unlike dihydrotestosterone, is not degraded on in vitro incubation with cytosol (Raynaud et al., 1979b; Krieg et al., 1979; Pousette et al., 1979; Tremblay et al., 1977), and both promegestone and dexamethasone form cytosolic receptor complexes that dissociate considerably more slowly than the corresponding progesterone complex (Raynaud et al., 1979b; Keightley, 1979; Jänne et al., 1978; Moguilewsky and Raynaud, 1977; Philibert and Raynaud, 1977) and hydrocortisone complex (Munck and Leung, 1977; Rousseau et al., 1972). Finally, if possible, tags should be more receptor-specific than the natural hormones. Hydrocortisone and aldosterone bind to at least two different tissue receptors, a mineralocorticoid and a glucocorticoid receptor, that are not easy to distinguish in the absence of ultraspecific radioligands (Raynaud et al., 1979a; Matulich et al., 1976; Rousseau et al., 1972).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allegra, J.C., Lippman, M.E., Thompson, E.B., Simon, R., Barlock, A., Green, L., Huff, K.K., Do, H.M.T., and Aitken, S.C., 1979a, Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast-cancer, Cancer Res. 39: 1447–1454.
Allegra, J.C., Lippman, M.E., Thompson, E.B., Simon, R., Barlock, A., Green, L., Huff, K.K., Do, H.M.T., Aitken, S.C., and Warren, R., 1979b, Relationship between the progesterone, androgen, and glucocorticoid receptor and response rate to endocrine therapy in metastatic breast cancer, Cancer Res. 39: 1973–1979.
Asselin, J., and Melançon, R., 1977, Characteristics of androgen binding in rat adrenal tissue using (3H)methyltrienolone (R1881) as tracer, Steroids 30: 591–604.
Asselin, J., Labrie, F., Gourdeau, Y., Bonne, C., and Raynaud, J.P., 1976a, Binding of (3H)methyltrienolone (R 1881) in rat prostate and human benign prostatic hypertrophy (BPH), Steroids 28: 449–459.
Asselin, J., Labrie, F., Kelly, P.A., Philibert, D., and Raynaud, J.P., 1976b, Specific progesterone receptors in dimethylbenzanthracene (DMBA)-induced mammary tumors, Steroids 27:395–404.
Asselin, J., Melançon, R., Gourdeau, Y., Labrie, F., Bonne, C., and Raynaud, J.P., 1979, Specific binding of 3H-methyltrienolone to both progestin and androgen binding components in human benign prostatic hypertrophy (BPH), J. Steroid Biochem. 10: 483–486.
Ballard, P.L., 1979, Delivery and transport of glucocorticoids to target cells, in: Glacocorticoid Hormone Action (J.D. Baxter and G.G. Rousseau, eds.), pp. 25–48, Springer-Verlag, Berlin.
Barnes, D.M., Ribeiro, G.G., and Skinner, L.G., 1977, Two methods for measurement of oestradiol-17ß and progesterone receptors in human breast cancer and correlation with response to treatment, Ear. J. Cancer 13: 1133–1143.
Bashirelahi, N., Young, J.D., and Sanefugi, H., 1978, Androgen and estrogen receptor distribution in epithelial and stroma cells of human prostate, Fed. Proc. Fed. Am. Soc. Exp. Biol. 37: 1312.
Blaustein, J.D., and Wade, G.N., 1978, Progestin binding by brain and pituitary cell nuclei and female rat sexual behavior, Brain Res. 140: 360–367.
Bonne, C., and Raynaud, J.P., 1975, Methyltrienolone, a specific ligand for cellular androgen receptors, Steroids 26: 227–232.
Bonne, C., and Raynaud, J.P., 1976, Assay of androgen binding sites by exchange with methyltrienolone (R 1881), Steroids 27: 497–507.
Bouton, M.M., and Raynaud, J.P., 1978, The relevance of kinetic parameters in. the determination of specific binding to the estrogen receptor, J. Steroid Biochem. 9: 9–15.
Bouton, M.M., Bonne, C., and Raynaud, J.P., 1978, In vitro“ screening for antihormones, J. Steroid Biochem. 9: 836.
Calandra, R.S., Purvis, K., Naess, O., Attramadal, A., Djoseland, O. and Hansson, V., 1978, Androgen receptors in the rat adrenal gland, J. Steroid Biochem. 9: 1009–1015.
Concolino, G., Marocchi, A., Tenaglia, R., DiSilverio, F., and Sparano, F., 1978, Specific progesterone receptor in human renal cancer, J. Steroid Biochem. 9: 399–402.
Cowan, R.A., Cowan, S.K., and Grant, J.K., 1977, Binding of methyltrienolone (R 1881) to a progesterone receptor-like component of human prostatic cytosol, J. Endocrino!. 74: 281–289.
Disorbo, D.,Rosen, F., McPartland, R.P., and Milholland, R.J., 1977, Glucocorticoid activity of various progesterone analogs: Correlation between specific binding in thymus and liver and biologic activity, Ann. N. Y. Acad. Sci. 286: 355–368.
Duffy, M.J., and Duffy, G.J., 1979, Studies on progesterone receptors in human breast carcinomas: Use of natural and synthetic ligands, Ear. J. Cancer 15: 1181–1184.
Ekman, P., Snochowski, M., Dahlberg, E., Bression, D. Högberg, B., and Gustafsson, J.A., 1979a, Steroid receptor content in cytosol from normal and hyperplastic human prostates, J. Clin. Endocrinol. Metab. 49: 205–215.
Ekman, P., Snochowski, M., Dahlberg, E. and Gustafsson, J.A., 19796, Steroid receptors in metastatic carcinoma of the human prostate, Eur. J. Cancer 15: 257–262.
Fleischmann, G., and Beato, M., 1978, Characterization of the progesterone receptor of rabbit uterus with the synthetic progestin, 16a-ethyl-21-hydroxy-19-norpregn-4-ene3,20-dione, Biochim. Biophys. Acta 540: 500–517.
Ghanadian, R., Auf, G., Chaloner, P.J., and Chisholm, G.D., 1978, The use of methyltrienolone in the measurement of the free and bound cytoplasmic receptors for dihydrotestosterone in benign hypertrophied human prostate, J. Steroid Biochem. 9: 325–330.
Gustafsson, J.A., Ekman, P., Snochowski, M., Zetterberg, A., Pousette, A., and Högberg, B., 1978, Correlation between clinical response to hormone therapy and steroid receptor content in prostatic cancer, Cancer Res. 38: 4345–4348.
Hähnel, R., and Twaddle E., 1979, Factors that may influence the estradiol receptor assay in human tissues: Sex hormone binding globulin and endogenous steroids, J. Steroid Biochem. 10: 95–98.
Hicks, L.L., and Walsh, P.C., 1979, A microassay for the measurement of androgen receptors in human prostatic tissue, Steroids 33: 389–406.
Horwitz, K.B., and McGuire, W.L., 1975, Specific progesterone receptors in human breast cancer, Steroids 25: 497–505.
Jänne, O., Kontula, K., and Vihko, R., 1976, Progestin receptors in human tissues: Concentrations and binding kinetics, J. Steroid Biochem. 7:1061–1068.
Jänne, O., Kontula, K., Vihko, R., Feil, P.D., and Bardin, C.W., 1978, Progesterone receptor and regulation of progestin action in mammalian tissues, Med. Biol. 56: 225–248.
Karr, J.P., Kirdani, R.Y., Murphy, G.Y., and Sandberg, A.A., 1978, Sex hormone binding globulin and transcortin in human and baboon males, Arch. Androl. 1: 123–129.
Kato, J., and Onouchi, T., 1979, Nuclear progesterone receptors and characterization of cytosol receptors in the rat hypothalamus and anterior hypophysis, J. Steroid Biochem. 11:845–854.
Keightley, D.D., 1979, The binding of progesterone, R-5020 and ORG-2058 to progesterone receptor, Eur. J. Cancer 15: 785–790.
Kent-Osborne, C., and McGuire, W.L., 1979, The use of steroid hormone receptors in the treatment of human breast cancer, Bull. Cancer 66: 203–210.
Kirchoff, J., Soffie, M., and Rousseau, G.G., 1979, Differences in the steroid binding site specificities of rat prostate androgen receptor and epididymal and androgen binding protein (ABP), J. Steroid Biochem. 10: 487–497.
Koenders, A.J.M., Geurts-Moespot, J., Beex, L.V.A.M., and Benraad, T.J., 1979, Assay of progesterone receptor binding sites with 17,21-dimethyl-19-norpregna-4,9-diene3,20-dione and 16a-ethyl-l9-nor-4-pregnene-3,20-dione as the radioactive ligands, J. Endocrinol. 80: 15 P.
Krieg, M., Bartsch, W., Janssen, W., and Voigt, K.D., 1979, A comparative study of binding, metabolism and endogenous levels of androgens in normal, hyperplastic and carcinomatous human prostate, J. Steroid Biochem. 11: 615–624.
Labrie, F., Ferland, L., Lagacé, L., Drouin, J., Asselin, J., Azadian-Boulanger, G., and Raynaud, J.P., 1977, High inhibitory activity of R 5020, a pure progestin, at the hypothalamo-adenohypophyseal level on gonadotropin secretion, Fertil. Steril. 28: 1104–1112.
Li, J.L., Li, S.A., and Gonzales, R., 1979, Specific steroid hormone binding in human renal carcinoma, Cancer Res. 20:273.
Lieberburg, 1., MacLusky, N.J., Roy, E.J., and McEwen, B.S., 1978, Sex steroid receptors in the perinatal rat brain, Am. Zoo. 22: 539–544.
MacLusky, N.J., Chaptal, C., and McEwen, B.S., 1979a, The development of estrogen receptor systems in the rat brain and pituitary: Postnatal development, Brain Res. 178:143–160.
MacLusky, N.J., Lieberburg, 1., and McEwen, B.S., 19796, The development of estrogen receptor systems in the rat brain: Perinatal development, Brain Res. 178:129–142.
Martin, P.M., Rolland, P.H., Jacquemier, J., Rolland, A.M., and Toga, M., 1978, Routine analysis of multiple steroid receptors in human breast cancer. I. Technological features, Biomedicine 28:278–287.
Martin, P.M., Rolland, P.H., Gammerre, M., Serment, H., and Toga, M., 1979, Estradiol and progesterone receptors in normal and neoplastic endometrium: Correlations between receptors, histopathological examinations and clinical responses under progestin therapy, Int. J. Cancer 23: 321–329.
Matsumoto, K., and Sugano, H. 1978, Human breast cancer and hormone receptors, in: Endocrine Control in Neoplasia (R.K. Sharma and W.E. Criss, eds.), pp. 191–208, Raven Press, New York.
Matulich, D.T., Spindler, B.J., Schambelan, M., and Baxter, J.D., 1976, Mineralocorticoid receptors in human kidney, J. Clin. Endocrinol. Metab. 43:1170–1174.
McEwen, B.S., Plapinger, L., Chaptal, C., Gerlach, J., and Wallach, G., 1975, Role of fetoneonatal estrogen binding proteins in the associations of estrogen with neonatal brain cell nuclear receptors, Brain Res. 96: 400–406.
McGuire, W.L. (ed.), 1978, Progress in Cancer Research and Therapy, Vol. 10, Hormones, Receptors, and Breast Cancer, Raven Press, New York.
McGuire, W.L., Horwitz, K.B., Pearson, O.H., and Segaloff, A., 1977a, Current status of estrogen and progesterone receptors in breast cancer, Cancer (Philadelphia) 39:2934–2947.
McGuire, W.L., Raynaud, J.P., and Baulieu, E.E. (eds), 19776, Progress in Cancer Research and Therapy,Vol. 4, Progesterone Receptors in Normal and Neoplastic Tissues,Raven Press, New York.
Menon, M., Tananis, C.E., Hicks, L.L. Hawkins, E.F., McLoughlin, M.G., and Walsh, P.C., 1978, Characterization of the binding of a potent synthetic androgen, methyltrienolone, to human tissues, J. Clin. Invest. 61:150–162.
Moguilewsky, M., and Raynaud, J.P., 1977, Progestin binding sites in the rat hypothalamus, pituitary and uterus, Steroids 30: 99–109.
Moguilewsky, M., and Raynaud, J.P., 1980, Evidence for a specific mineralocorticoid receptor in rat pituitary and brain, J. Steroid Biochem. 12: 309–314.
Munck, A., and Leung, K., 1977, Glucocorticoid receptors and mechanisms of action, in: Receptors and Mechanism of Action of Steroid Hormones, Vol. 8, Part II (J.R.Pasqualini, ed.), pp. 311–397, Marcel Dekker, New York.
Naftolin, F., Ryan, K.J., Davies, I.J., Reddy, V.V., Flores, F., Petro, Z., and Kuhn, M., 1975, The formation of estrogens by central neuroendocrine tissues, Recent Prog. Harm. Res. 31:295–319.
Ojasoo, T., and Raynaud, J.P., 1978, Unique steroid congeners for receptor studies, Cancer Res. 38: 4186–4198.
Okret, S., Wrange, O., Nordenskjöld, B., Silfverswärd, C., and Gustafsson, J.A., 1978
Estrogen receptor assay in human mammary carcinoma with the synthetic estrogen 110-methoxy-17a-ethynyl-1,3,5(10)-estratriene-3,17ß-diol (R2858) Cancer Res. 38:3904–3909.
Pertschuk, L.Y., Zava, D.T., Gaetjens, E., Macchia, R.J., Brigati, D.J., and Kim, D.S., 1978, Detection of androgen and estrogen receptors in human prostatic carcinoma and hyperplasia by fluorescence microscopy, Res. Commun. Chem. Pathol. Pharmacol. 22: 427–430.
Philibert, D., and Raynaud, J.Y., 1973, Progesterone binding in the immature mouse and rat uterus, Steroids 22: 89–98.
Philibert, D., and Raynaud, J.P., 1974a, Progesterone binding in the immature rabbit and guinea pig uterus, Endocrinology 94: 627–632.
Philibert, D., and Raynaud, J.P., 1974b, Binding of progesterone and R 5020, a highly potent progestin, to human endometrium and myometrium, Contraception 10: 457–466.
Philibert, D., and Raynaud, J.P., 1977, Cytoplasmic progestin receptors in mouse uterus, in: Progesterone Receptors in Normal and Neoplastic Tissues ( W.L. McGuire, J.P. Raynaud, and E.E. Baulieu, eds.), pp. 227–243, Raven Press, New York.
Plapinger, L., Landau, I.T., McEwen, B.S., and Feder, H.H., 1977, Characteristics of estradiol-binding macromolecules in fetal and adult guinea pig brain cytosols, Biol. Reprod. 16: 586–599.
Pollow, K., Schmidt-Gollwitzer, M., and Pollow, B., 1978, Characterization of a cytoplasmic receptor for progesterone in normal and neoplastic human endometrial tissues, J. Mol. Med. 3: 55–69.
Pousette, A., Snochowski, M., Bression, D., Högberg, B., and Gustafsson, J.Â., 1979, Partial characterization of (31–1)methyltrienolone binding in rat prostate cytosol, Biochim. Biophys. Acta 582: 358–367.
Pujol, A., and Bayard, F., 1979, Androgen receptors in the rat epididymis and their hormonal control, J. Reprod. Fertil. 56: 217–222.
Raynaud, J.P., 1973, Influence of rat estradiol binding plasma protein (EBP) on uterotrophic activity, Steroids 21: 249–258.
Raynaud, J.P., 1974, Estrogen interactions at the hypothalamic subcellular level, in: Drug Interactions ( P.L. Morselli, S. Garattini, and S.N. Cohen, eds.), pp. 151–162, Raven Press, New York.
Raynaud, J.Y., 1978, The mechanism of action of anti-hormones, in: Advances in Pharmacology and Therapeutics, Vol. 1, Receptors ( J. Jacob, ed.), pp. 259–278, Pergamon Press, Oxford.
Raynaud, J.P., and Moguilewsky, M., 1976, Ontogenèse des récepteurs des oestrogènes chez le rat, in: Système Nerveux, Activité Sexuelle et Reproduction ( A. Soulairac, J.P. Gautray, J.P. Rousseau, and J. Cohen, eds.), pp. 85–92, Masson, Paris.
Raynaud, J.P., and Moguilewsky, M., 1977, Steroid competitition for estrogen receptors in the central nervous system, in: Progress in Reproductive Biology, Vol. 2, Clinical Reproductive Neuroendocrinology ( P.O. Hubinont, M. L’Hermite, and C. Robyn, eds.), pp. 78–87, S. Karger, Basel.
Raynaud, J.P., Martin, P., Bouton, M.M., and Ojasoo, T., 1978, I lß-Methoxy-17-ethynyl1,3,5(10)-estratriene-3,17/3-diol (Moxestrol), a tag for estrogen receptor-binding sites in human tissues, Cancer Res. 38: 3044–3050.
Raynaud, J.P., Ojasoo, T., Bouton, M.M., and Philibert, D., 1979a, Receptor binding as a tool in the development of new bioactive steroids, in: Drug Design, Vol. VIII ( E.J. Ariens, ed.), pp. 169–214, Academic Press, New York.
Raynaud, J.P., Ojasoo, T. and Vaché, V., 1979b, Unusual steroids in measuring steroid receptors, in: Steroid Receptors and the Management of Cancer, Vol. 1 ( E.B. Thompson and M.E. Lippman, eds.), pp. 215–232, CRC Press, Boca Raton.
Raynaud, J.P., Bouton, M.M., and Martin, P.M., 1980a, Steroid prostate hyperplasia and adenocarcinoma: Steroid hormone receptor assays and therapy, in: Steroid Receptors, Metabolism and Prostatic Cancer ( F.H. Schröder and H.J. de Voogt, eds.), pp. 165–181, Excerpta Medica, Amsterdam.
Raynaud, J.P., Bouton, M.M., Moguilewsky, M., Ojasoo, T., Philibert, D., Beck, G., Labrie, F., and Mornon, J.P., 1980b, Steroid hormone receptors and pharmacology, J. Steroid Biochem. 12: 143–158.
Raynaud, J.P., Brown, N., Coussediere, D., Pottier, J., Delettré, J., and Mornon, J.P., 1980c, Role of metabolism and receptor binding in progestin-induced responses in the uterus, in: Steroid-Induced Uterine Proteins ( M. Beato, ed.), pp. 217–236, Elsevier North-Holland, Biomedical Press, Amsterdam.
Raynaud, J.P., Moguilewsky, M., and Vannier, B., 1980d, Influence of rat estradiol binding plasma protein (EBP) on estrogen binding to its receptor and on induced biological responses, in: Development of Responsiveness to Steroid Hormones ( A.M. Kaye and M. Kaye, eds.), pp. 59–75, Pergamon Press, Oxford.
Rousseau, G.G., and Baxter, J.D., 1979, Glucocorticoid receptors, in: Glucocorticoid Hormone Action ( J.D. Baxter and G.G. Rousseau, eds.), pp. 50–77, Springer-Verlag, Berlin.
Rousseau, G., Baxter, J.D., Funder, J.W., Edelman, I.S., and Tomkins, G.M., 1972, Glucocorticoid and mineralocorticoid receptors for aldosterone, J. Steroid Biochem. 3: 219–227.
Saez, S., Martin, P.M., and Cignoux, B., 1979, Androgen receptors in the normal mucosa and in epithelioma of human larynx and pharynx, in: Steroid Receptors and the Management of Cancer, Vol. 1 ( E.B. Thompson and M.E. Lippman, eds.), pp. 205–213, CRC Press, Boca Raton.
Salmon, J., Raynaud, J.P., and Pottier, J., 1971, Etude métabolique d’un stéroïde triénique: le R 1881, in: Symposium sur les Progrés des Techniques Nucléaires en Pharmaco- dynamie, Saclay, 1970 ( G. Valette and Y. Cohen, eds.), pp. 237–247, Masson, Paris.
Shain, S.A., and Boesel, R.W., 1978, Human prostate steroid hormone receptor quantitation: Current methodology and possible utility as a clinical discriminant in carcinoma, Invest. Urol. 16: 169–174.
Stoa, K.F., Hekim, N., Dahl, O., and Horsaeter, P.A., 1979, Binding of androgens and progestins in the human testis, J. Steroid Biochem. 11: 261–265.
Tamaya, T., Motoyama, T., Ohono, Y., Ide, N., Tsurusaki, T., and Okada, H., 1979, Estradiol-l7ß, progesterone and 5a-dihydrotestosterone receptors of uterine myometrium and myoma in the human subject, J. Steroid Biochem. 10: 615–622.
Tremblay, R.R., Dubé, J.Y., Ho-Kim, M.A., and Lesage, R., 1977, Determination of rat muscles androgen-receptor complexes with methyltrienolone, Steroids 29: 185–195.
Verhoeven, G., 1979, Androgen binding proteins in mouse submandibular gland, J. Steroid Biochem, 10:129–138.
Vu Hai, M.T., and Milgrom, E., 1978, Characterization and assay of the progesterone receptor in rat uterine nuclei, J. Endocrinol. 76:33–41.
Wagner, R.K., 1978, Extracellular and intracellular steroid binding proteins: Properties, discrimination, assay and clinical applications, Acta Endocrinol. (Copenhagen) 88 (Suppl. 218): 1–73.
Walsh, P.C., Hicks, L.L., Reiner, W.G., and Trachtenberg, J., 1979, The use of androgen receptors to predict the duration of hormonal response in prostatic cancer, in: Abstracts, Meeting of the American Urological Association, New York.
Westphal, U., 1971, Steroid—Protein Interactions, Springer-Verlag, Berlin.
Zava, D.T., Landrum, B., Horwitz, K.B., and McGuire, W.L., 1979, Androgen receptor assay with (3H)methyltrienolone (R1881) in the presence of progesterone receptors, Endocrinology, 104: 1007–1012.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Plenum Press, New York
About this chapter
Cite this chapter
Raynaud, JP., Ojasoo, T., Vaché, V. (1981). Stable and Specific Tracers. In: McKerns, K.W. (eds) Reproductive Processes and Contraception. Biochemical Endocrinology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3824-6_7
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3824-6_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3826-0
Online ISBN: 978-1-4684-3824-6
eBook Packages: Springer Book Archive